Abstract

Coxsackievirus B3 (CVB3) is a single-stranded positive RNA virus that usurps cellular machinery, including the evolutionarily anti-viral autophagy pathway, for productive infections. Despite the emergence of double-membraned autophagosome-like vesicles during CVB3 infection, very little is known about the mechanism of autophagy initiation. In this study, we investigated the role of established autophagy factors in the initiation of CVB3-induced autophagy. Using siRNA-mediated gene-silencing and CRISPR-Cas9-based gene-editing in culture cells, we discovered that CVB3 bypasses the ULK1/2 and PI3K complexes to trigger autophagy. Moreover, we found that CVB3-induced LC3 lipidation occurred independent of WIPI2 and the transmembrane protein ATG9 but required components of the late-stage ubiquitin-like ATG conjugation system including ATG5 and ATG16L1. Remarkably, we showed the canonical autophagy factor ULK1 was cleaved through the catalytic activity of the viral proteinase 3C. Mutagenesis experiments identified the cleavage site of ULK1 after Q524, which separates its N-terminal kinase domain from C-terminal substrate binding domain. Finally, we uncovered PI4KIIIβ (a PI4P kinase), but not PI3P or PI5P kinases as requisites for CVB3-induced LC3 lipidation. Taken together, our studies reveal that CVB3 initiates a non-canonical form of autophagy that bypasses ULK1/2 and PI3K signaling pathways to ultimately converge on PI4KIIIβ- and ATG5–ATG12–ATG16L1 machinery.

Details

Title
Coxsackievirus infection induces a non-canonical autophagy independent of the ULK and PI3K complexes
Author
Mohamud Yasir 1 ; Shi Junyan 1 ; Tang, Hui 2 ; Pinhao, Xiang 1 ; Xue Yuan Chao 1 ; Liu Huitao 1 ; Ng, Chen Seng 1 ; Luo Honglin 1 

 St. Paul’s Hospital, Centre for Heart Lung Innovation, Vancouver, Canada (GRID:grid.416553.0) (ISNI:0000 0000 8589 2327); University of British Columbia, Department of Pathology and Laboratory Medicine, Vancouver, Canada (GRID:grid.17091.3e) (ISNI:0000 0001 2288 9830) 
 St. Paul’s Hospital, Centre for Heart Lung Innovation, Vancouver, Canada (GRID:grid.416553.0) (ISNI:0000 0000 8589 2327); Shandong Provincial Hospital Affiliated to Shandong First Medical University, Department of Pharmacy, Jinan, People’s Republic of China (GRID:grid.460018.b) (ISNI:0000 0004 1769 9639) 
Publication year
2020
Publication date
2020
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2471552953
Copyright
© The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.